GLP-1 RAs may offer a beneficial approach for managing diabetes in individuals with COPD [49]
By signing up, you unlock trusted, personalized guidance before your treatment even begins.
This is further exacerbated if the individual in question has relied solely on GLP-1 to do the heavy lifting during weight loss, he said, rather than making behavioral changes
Additionally, this model will provide access to a lifestyle support program to promote healthy behaviors and increase the effectiveness of GLP-1s, which could provide improvements in health along with sustained weight reduction
Clinical Trial Evidence: Landmark cardiovascular outcome trials (CVOTs) like the SELECT trial (for semaglutide) have shown a significant reduction in major adverse cardiovascular events (MACE), including heart attack, stroke, and cardiovascular death
This product should not be consumed by pregnant or lactating women or children below 18 years old